WALL, N.J., Nov. 29, 2010 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (OTCBB:BKYI) , a leader in finger-based biometric identification solutions, announced the successful deployment by Genesis HealthCare System, based in Zanesville, Ohio, of BIO-key's biometric identification for staff to quickly, conveniently and securely establish their identity when ordering, verifying or administering medications as required by Ohio law.
"Our fingerprint identification software is approved by the Ohio Pharmacy Board for two-factor authentication and complies with the new DEA e-prescription two-factor rules for dispensing controlled substances," commented Mike DePasquale, CEO of BIO-key International. "This is the perfect solution to protect access to EMRs, not only for healthcare organizations in Ohio, but across the whole nation."
In the initial rollout, 2,000 clinicians and staff use fingerprint biometrics to establish their identity in Genesis's Epic software to order, verify or administer medications. In the next phase of this project, Genesis is implementing fingerprint biometric user logon with Vergence, a single sign-on solution from Sentillion, a Microsoft company. With these solutions in place, Genesis staff members can instantly establish their identity with the simple touch of a finger, giving them faster access to the systems they are authorized to use.
"Sentillion Vergence is designed to improve caregiver productivity and satisfaction by making single sign-on virtually transparent within existing clinical workflows," said Marguerite Yeo, director of product marketing, Microsoft. "We're pleased that Genesis and other healthcare providers can take advantage of BIO-key's fingerprint identification with Vergence to accelerate caregivers' access to IT systems and allow them to spend more time interacting with patients."
Genesis HealthCare System is a not-for-profit organization that operates two hospital sites, Genesis-Bethesda and Genesis-Good Samaritan in Zanesville, Ohio, and several affiliated health care organizations. Its primary service area is a six-county region of southeastern Ohio.
"BIO-key's ability to operate with every major fingerprint reader manufacturer allowed us to evaluate various readers to determine which would work best in our environment. As a result of our testing, we determined that Lumidigm's Mercury sensor provided us with the best performance. We have seamlessly integrated BIO-key's identification solution into our operation to comply with the Ohio Pharmacy Board for two-factor authentication. It is convenient and easy to use, streamlines our processes and improves our system's security," said Ed Romito, Vice President and CIO of Genesis Healthcare System.
BIO-key International, Inc., headquartered in Wall, New Jersey, develops and delivers advanced identification solutions to commercial and government enterprises, integrators, and custom application developers. BIO-key's award winning, high performance, scalable, cost-effective and easy-to-deploy biometric finger identification technology accurately identifies and authenticates users of wireless and enterprise applications. Our solutions are used in local embedded OEM products as well as some of the world's largest identification deployments to improve security, guarantee identity, and help reduce identity theft. BIO-key's technology is offered directly or by market leading partners around the world. ()
BIO-key Safe Harbor Statement
Certain statements contained in this press release may be construed as "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 (the "Act"). The words "estimate," "project," "intends," "expects," "anticipates," "believes" and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management's beliefs, as well as assumptions made by, and information currently available to, management pursuant to the "safe-harbor" provisions of the Act. These statements are subject to certain risks and uncertainties that may cause actual results to differ materially from those projected on the basis of these statements. These risks and uncertainties include, without limitation, our history of losses and limited revenue, our ability to develop new products and evolve existing ones, the impact on our business of the recent financial crisis in the global capital markets and negative global economic trends, and our ability to attract and retain key personnel. For a more complete description of these and other risk factors that may affect the future performance of BIO-key International, Inc., see "Risk Factors" in the Company's Annual Report on Form 10-K for the year ended December 31, 2009 and its other filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. The Company also undertakes no obligation to disclose any revision to these forward-looking statements to reflect events or circumstances after the date made or to reflect the occurrence of unanticipated events.
CONTACT: BIO-key International, Inc. Bud Yanak 732-359-1100